Fine-Needle Aspiration Biopsy Cytopathology of Breast Lesions Using the International Academy of Cytology Yokohama System and Rapid On-Site Evaluation: A Single-Institute Experience
- 27 August 2021
- journal article
- research article
- Published by S. Karger AG in Acta Cytologica
- Vol. 65 (6), 463-477
- https://doi.org/10.1159/000518375
Abstract
Introduction: Breast cancer is rapidly emerging as the leading cause of cancer in Indian women. Robust cytopathology and histopathology services are required to tackle this growing burden. The use of rapid on-site evaluation (ROSE) and the International Academy of Cytology (IAC) Yokohama System for Reporting Breast Fine-Needle Aspiration Biopsy (FNAB) Cytopathology, which offers structured protocols, are expected to improve breast cytopathology reporting. Methods: We retrieved the cytopathology slides, categorized them by the IAC Yokohama System and histopathology data of all the patients who had been investigated for breast lesions from September 2016 to December 2018, and compared the cytopathology and histopathology. Risk of malignancy (ROM) and performance metrics, like sensitivity, specificity, predictive values, accuracy, and area under the curve were computed. Results: A total of 1,147 FNABs were evaluated, of which 442 (38.5%) underwent ROSE and 624 (54.4%) histopathology. Reported using IAC categories, our cohort recorded 4.9% inadequate, 65.3% benign, 7.8% atypical, 3.3% suspicious for malignancy, and 18.7% malignant lesions. The overall sensitivity and specificity for identifying in situ and malignant lesions were 99.1% and 99.3%, respectively, and were substantially improved by ROSE. ROSE improved the concordance between cytopathology and histopathology from 76.9% to 90.2%, by reducing inadequate (p < 0.001) cases. The ROM increased along a gradient from inadequate to malignant categories, with the gradient being sharpened by ROSE. The false negativity rate was 0.7% and false positivity rate 0%. Conclusion: Incorporating ROSE and the IAC Yokohama System for breast cytopathology reporting improves accurate diagnosis of breast lesions, prevents missed diagnoses, and provides reliable estimates of ROM. These protocols also aid in standardizing a reproducible system for monitoring and auditing of breast pathology services, identify areas that need strengthening, and improve training at pathology centers.Keywords
This publication has 31 references indexed in Scilit:
- FNAC Versus Core Needle Biopsy: A Comparative Study in Evaluation of Palpable Breast LumpJournal of Clinical and Diagnostic Research, 2016
- CYTOMORPHOLOGIC AL STUDY OF BREAST LESIONS WITH SONOMAMMOGRAPHIC CORRELATIONJournal of Evolution of Medical and Dental Sciences, 2015
- Comparative study of core needle biopsy and fine needle aspiration cytology in palpable breast lumps: scenario in developing nationsTurkish Journal of Pathology, 2015
- Fine-needle aspiration cytology samples: a good source of material for evaluating biomarkers in breast cancerHistopathology, 2014
- Comparison between fine needle aspiration cytology (FNAC) and core needle biopsy (CNB) in the diagnosis of breast lesionsIl Giornale di Chirurgia - Journal of the Italian Association of Hospital Surgeons, 2014
- Cytological and Pathological Correlation of FNAC in Assessing Breast Lumps and Axillary Lymph Node Swellings in a Public Sector Hospital in IndiaPathology Research International, 2013
- The value of systematic pattern analysis in FNAC of breast lesions: 225 cases with cytohistological correlationJournal of Cytology, 2011
- Core needle biopsy versus fine needle aspiration biopsy in breast—A historical perspective and opportunities in the modern eraDiagnostic Cytopathology, 2010
- Cost Modeling of Preoperative Axillary Ultrasound and Fine-Needle Aspiration to Guide Surgery for Invasive Breast CancerAnnals of Surgical Oncology, 2010
- Utility of cytologic specimens in the evaluation of prognostic and predictive factors of breast cancer: Current issues and future directionsDiagnostic Cytopathology, 2004